In diabetes, mice lacking Smad3 are protected against both renal and cardiac fibrosis in streptozotocin (STZ)‐induced type 1 diabetes and in obese diabetic mice.10, 27, 28. Here, SMAD3 is linked to type 1 diabetes mellitus.